GBT Technologies Inc (OTCMKTS:GTCH) stock continues to move in a narrow range as the stock ended flat in the previous trading despite the news.
In Wednesday’s trading session, GTCH stock ended flat to $0.0100 with more than 4.29 million shares, compared to its average volume of 3.07million shares. Over the past 52-week, the stock has moved within a range of $0.0090 – 0.1000.
GBT Has Concluded – qTerm GEN III Prototype Large Scale Testing
GBT Technologies concluded its large-scale testing for its qTerm GEN III prototype device. Based on the collected data GBT will attempt to finalize the device’s accuracy and features. The company developed a web-based widget to demonstrate telemedicine capabilities. The widget enables viewing a user’s vitals anywhere in the world through a web-based interface. The widget includes analytics, historical data recordation and categorization of abnormal results.
The GEN III release will include a series of enhancements for higher accuracy, consistency, and visual feedback to support broader user’s usages and behaviors. GBT’s qTerm, a human vitals intelligent device is targeted to measure human vitals with a touch of a finger. Based on this larger scale testing the company will make the enclosure’s shape changes and code modifications to enhance user’s guidance during the measurement process.
This device includes sensors for oxygen (SPO2), heart rate and IR (Infra-Red) type for temperature including a coprocessor chip that provides advanced calibration algorithm to assist users with qTerm’s usage. The device is accompanied by a smartphone app and a new synchronized widget web application to keep a history and provide health analytics. The widget reads the device’s data and presenting it on a graph to show vitals history and abnormalities.
“GEN III version improvements will significantly increase the device’s overall performance, accuracy, and consistency and with its accompanied web application widget, it can offer a real time medical information observation in remote places or simply from home. Our Artificial Intelligence technology is aimed to process the widget data and provide a 24/7 medical monitoring in a later stage. The web widget will be soon available on qTerm’s web site at www.qterm.me. As a courtesy for the public, we will provide a demo device data for demonstration purposes. During the next few months we plan to conclude the qTerm device and approach potential domain for its commercialization. We believe that this type of technology can become an essential health monitoring assistant at any time and place, keeping our lives healthier and safer.” Said Danny Rittman, the Company’s CTO.